FORT WORTH, Texas — American Airlines, in collaboration with Stand Up To Cancer (SU2C), is launching its annual campaign to raise funds for innovative and life-saving cancer research and inviting customers to be a part of the efforts.

Those who choose to donate online $25 or more will receive 25 bonus American Airlines AAdvantage miles for every dollar donated. And thanks to Mastercard, those who donate online using their American Airlines AAdvantage Mastercard credit card will receive 50 bonus American Airlines AAdvantage® miles per dollar, up to $3 million donated. Promotion ends Sept. 30, 2023, or when overall promotion donations total $3 million, whichever is earlier.^*

On Aug. 19, SU2C hosted its eighth biennial roadblock televised fundraising special supporting urgently needed research and new treatments for cancer, which included a celebration of the official launch of this year’s fundraising campaign. Viewers enjoyed a video featuring American Airlines Chief Executive Officer Robert Isom and American team members whose lives have been touched by cancer, reflecting on the airline’s collaboration with and commitment to the long-standing relationship with SU2C.

“Throughout our seven-year collaboration with Stand Up To Cancer, the support from our generous team members and customers has been remarkable,” Isom said. “We are grateful for the opportunity to collaborate with Stand Up To Cancer and advance their mission to raise funds and continue accelerating the pace of groundbreaking research.”

Since first joining forces in 2016, American has raised more than $17.5 million to benefit SU2C through fundraising efforts. In 2019, American debuted a campaign that offered those who donate the chance to honor a loved one by including their name on an Airbus A321 aircraft wrapped in a special SU2C livery.

“Tackling cancer is a community effort, which is why we’re so grateful for our long-term supporters, American Airlines, and their generous customers,” said Rusty Robertson, Co-Founder of Stand Up To Cancer. “This year, nearly 2 million people in the U.S. will be diagnosed with cancer and their long-term survival depends on the work of scientists to discover new, life-saving treatments. We’re hopeful Stand Up To Cancer-funded research will continue to help solve this disease’s biggest and most urgent challenges. Our donors help to make it all possible.”

SU2C brings together the best and the brightest in the cancer community to help new therapies move from the laboratory to the patient quickly. By galvanizing the entertainment community, SU2C creates awareness and educates the public on cancer prevention, diagnosis, and treatment and raises funds to support these efforts.

Learn more about the 2023 fundraising campaign and learn more about how to donate at su2c/aa.com.

*Terms and conditions apply.

About American Airlines Group
To Care for People on Life’s Journey®. Shares of American Airlines Group Inc. trade on Nasdaq under the ticker symbol AAL and the company’s stock is included in the S&P 500. Learn more about what’s happening at American by visiting news.aa.com and connect with American on Twitter @AmericanAir and at Facebook.com/AmericanAirlines.

About Stand Up To Cancer
Stand Up To Cancer® (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C is a 501(c)(3) charitable organization and was initially launched as a division of the Entertainment Industry Foundation. Established in 2008 by media and entertainment leaders, SU2C utilizes these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of April 2023, more than 3,000 scientists representing more than 210 institutions are involved in SU2C-funded research projects.

As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, Ph.D., conduct rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.

Current members of the SU2C Founders and Advisors Committee (FAC) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Russell Chew serves as SU2C’s president and CEO.

For more information, visit StandUpToCancer.org, Instagram, TikTok, Twitter, Facebook, and YouTube.